View Older Stories View More Recent Stories

May 19, 2025 09:59AM UBS Reiterates Buy Rating on Merck (MRK)
May 19, 2025 07:01AM IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 15, 2025 06:45AM Merck (MRK) Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival
May 14, 2025 05:30PM Merck (MRK) announces FDA approval of WELIREG
May 14, 2025 05:06AM Citi Downgrades Merck (MRK) to Neutral
May 13, 2025 02:44PM Evercore ISI Reiterates Outperform Rating on Halozyme Therapeutics (HALO)
May 7, 2025 04:32PM Trump to pitch sweeping Medicare drug price plan - Politico
May 7, 2025 05:26AM Merck (MRK) call put ratio 1 call to 1.3 puts
May 3, 2025 10:00AM What is the impact of U.S. tariffs on biopharma sector?
May 1, 2025 04:47PM Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm
May 1, 2025 11:01AM WHO to Back Use of Weight-loss Drugs for Adults Globally, Raises Cost Issue - Reuters
May 1, 2025 09:36AM Amazon (AMZN) Comments Circulate
Apr 30, 2025 07:50AM Merck (MRK) PT Lowered to $108 at Guggenheim
Apr 29, 2025 06:57AM Merck (MRK) Breaks Ground on New $1B Biologics Center of Excellence in Wilmington, Delaware
Apr 29, 2025 05:35AM Merck to Spend $1 Billion on New Factory to Make US Supplies of Blockbuster Drug - WSJ
Apr 28, 2025 02:07AM Merck Kgaa To Buy Springworks For $47 Per Share In Cash- Bloomberg
Apr 24, 2025 08:34AM Halozyme Therapeutics (HALO) Sues Merck (MRK) for Patent Infringement over Subcutaneous Keytruda Formulation
Apr 24, 2025 06:43AM Merck (MRK) Tops Q1 EPS by 8c; updates guidance
Apr 24, 2025 05:00AM Merck & Co. Q1 preview: Here’s what Wells Fargo expects to see
Apr 23, 2025 11:11AM Merck (MRK) call put ratio 1.2 calls to 1 put into quarter results
Apr 23, 2025 05:44AM Merck (MRK) call put ratio 2.2 calls to 1 put into quarter results
Apr 22, 2025 07:21AM Cantor Fitzgerald Starts Merck (MRK) at Neutral
Apr 17, 2025 10:22AM UBS Reiterates Buy Rating on Merck (MRK)
Apr 11, 2025 12:21PM MRK IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important April 14 Deadline in Securities Class Ac
Apr 10, 2025 12:14PM MRK FINAL DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 8, 2025 04:00PM MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 8, 2025 02:40PM MRK DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK
Apr 8, 2025 05:07AM Goldman Sachs Assumes Merck (MRK) at Buy
Apr 7, 2025 06:48PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
Apr 6, 2025 12:26PM MRK FINAL DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Clas
Apr 4, 2025 01:17PM MRK FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Actio
Apr 3, 2025 01:11PM MRK FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - M
Apr 3, 2025 09:44AM UBS Reiterates Buy Rating on Merck (MRK)
Apr 2, 2025 04:00PM MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 1, 2025 06:06PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks
Mar 31, 2025 07:39PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
Mar 31, 2025 01:58PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Mar 31, 2025 10:00AM Merck (MRK) Report WINREVAIR Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76%
Mar 29, 2025 09:19AM ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Mar 29, 2025 07:44AM MRK Investors Have Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Mar 27, 2025 04:04PM MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 27, 2025 11:01AM Merck (MRK) Reports Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous KEYTRUDA
Mar 27, 2025 09:54AM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 26, 2025 06:45AM Merck (MRK) Receives EU Approval for CAPVAXIVE for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
Mar 25, 2025 03:35PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
Mar 25, 2025 09:57AM Citi Reiterates Buy Rating on Merck (MRK)
Mar 25, 2025 06:45AM Merck (MRK) Enters Exclusive License Agreement for HRS-5346
View More Recent Stories View Older Stories